Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2026-02-25 @ 11:47 PM
Study NCT ID:
NCT04882033
Status:
UNKNOWN
Last Update Posted:
2021-05-11
First Post:
2021-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-07
First Submit QC Date:
None
Study First Post Date:
2021-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-07
Last Update Post Date:
2021-05-11
Last Update Post Date Type:
ACTUAL